Skip to content
TriangleGet started
← Back to this collection

PUBLICATIONS · 33862000

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet Oncol
Publication date
2021 May
First author
Conroy T

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2021 May;22(5):575-577. doi: 10.1016/S1470-2045(21)00127-3.
    note
    Source null
    related pmid
    33861999
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2021 Jul;22(7):e301. doi: 10.1016/S1470-2045(21)00304-1.
    note
    Source null
    related pmid
    34197761
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2021 Jul;22(7):e302. doi: 10.1016/S1470-2045(21)00340-5.
    note
    Source null
    related pmid
    34197762
    relationship
    Comment in
  4. citation
    Clin Colorectal Cancer. 2022 Mar;21(1):e21. doi: 10.1016/j.clcc.2021.11.005.
    note
    Source null
    related pmid
    34949551
    relationship
    Comment in

Authors and identifiers

  1. name
    Conroy T
    type
    Author
  2. name
    Bosset JF
    type
    Author
  3. name
    Etienne PL
    type
    Author
  4. name
    Rio E
    type
    Author
  5. name
    François É
    type
    Author
  6. name
    Mesgouez-Nebout N
    type
    Author
  7. name
    Vendrely V
    type
    Author
  8. name
    Artignan X
    type
    Author
  9. name
    Bouché O
    type
    Author
  10. name
    Gargot D
    type
    Author
  11. name
    Boige V
    type
    Author
  12. name
    Bonichon-Lamichhane N
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Conroy T
    type
    Author
  2. name
    Bosset JF
    type
    Author
  3. name
    Etienne PL
    type
    Author
  4. name
    Rio E
    type
    Author
  5. name
    François É
    type
    Author
  6. name
    Mesgouez-Nebout N
    type
    Author
  7. name
    Vendrely V
    type
    Author
  8. name
    Artignan X
    type
    Author
  9. name
    Bouché O
    type
    Author
  10. name
    Gargot D
    type
    Author
  11. name
    Boige V
    type
    Author
  12. name
    Bonichon-Lamichhane N
    type
    Author
bibliography ids
  1. nci-bib-323f359e0fc3e5eab1cdccf6
book metadata
content sha256
aa64b1b7d7a2be978f5e3466523a3a5f26d77caa700b3cd8fab5538944dc3431
document type
citation
dois
  1. 10.1016/S1470-2045(21)00079-6
electronic publication date
display
2021 Apr 13
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:33862000
immutable id
pubmed:33862000@aa64b1b7d7a2be978f5e3466523a3a5f26d77caa700b3cd8fab5538944dc3431
journal
abbreviation
Lancet Oncol
issn electronic
1474-5488
issn print
1470-2045
issue
5
name
The Lancet. Oncology
nlm unique id
100957246
pages
702-715
volume
22
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet Oncol. 2021 May;22(5):575-577. doi: 10.1016/S1470-2045(21)00127-3.
    note
    Source null
    related pmid
    33861999
    relationship
    Comment in
  2. citation
    Lancet Oncol. 2021 Jul;22(7):e301. doi: 10.1016/S1470-2045(21)00304-1.
    note
    Source null
    related pmid
    34197761
    relationship
    Comment in
  3. citation
    Lancet Oncol. 2021 Jul;22(7):e302. doi: 10.1016/S1470-2045(21)00340-5.
    note
    Source null
    related pmid
    34197762
    relationship
    Comment in
  4. citation
    Clin Colorectal Cancer. 2022 Mar;21(1):e21. doi: 10.1016/j.clcc.2021.11.005.
    note
    Source null
    related pmid
    34949551
    relationship
    Comment in
outcomes validated
false
pmid
33862000
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
377038061d9f375d5d670b994b4784171bdafcb21435336fbdefa104f7fee49c
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 May
precision
month
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33862000/
title
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.

Preserved source evidence · Independent clinical review pending · Not medical advice